Answers are grounded in this paper and cite their sources.
This Matters Arising commentary addresses the recent article by Patidar et al. ( 2026 ) on TTK-mediated ceRNA networks in lung adenocarcinoma. We identify two critical scientific issues that are not addressed in the original paper’s Limitations section. First, the authors interpret molecular docking scores as evidence of binding affinity and inhibitory activity, which is scientifically unsupported. Second, the therapeutic recommendation for hesperidin lacks any functional validation, as no enzymatic, cellular, or in vivo assays were performed. These concerns fundamentally affect the validity of the paper’s therapeutic conclusions and warrant clarification.
No takes yet. Share an insight, caveat, or question.
Ehsan Khodamoradi (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: